Related Experiment Videos
Insulin-like growth factor-mediated phosphorylation and protooncogene induction in Madin-Darby canine kidney cells
S Hauguel-de Mouzon1, C R Kahn
1Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215.
Abstract:
We have characterized the role of tyrosine phosphorylation in protooncogene induction mediated by insulin-like growth factors I and II (IGF-I and IGF-II) in the Madin-Darby canine kidney (MDCK) cell line. These cells possess few, if any, insulin receptors, thus allowing determination of the effects of these growth factors in the absence of any secondary signal mediated through the insulin receptor. We found that IGF-I produced a specific stimulation of tyrosine kinase activity of the 97-kDa beta-subunit of the IGF-I receptor, resulting in autophosphorylation of the receptor and an increase in kinase activity toward a synthetic peptide substrate. This was associated with a gradual decrease in the level of phosphorylation of pp120, the major constitutive phosphotyrosine-containing protein of MDCK cells, and an increase in the ratio of serine to tyrosine phosphorylation. This was followed by a rapid, but transient, induction of c-fos gene expression, with no change in the levels of c-myc mRNA. Cycloheximide treatment resulted in a superinduction of both c-fos and c-myc and prevented any further stimulation by IGF-I. IGF-II did not stimulate tyrosine phosphorylation of its own receptor, but was 25% as active as IGF-I in stimulating phosphorylation of the IGF-I receptor. Despite this, IGF-II did not significantly enhance the expression of either nuclear protooncogene. Insulin also produced a delayed stimulation of IGF-I receptor phosphorylation, but was unable to stimulate biological effects in these cells. Under these conditions neither of the IGFs nor insulin produced any significant stimulation of thymidine incorporation into DNA. These data indicate that the IGF-I receptor can be activated upon binding of IGF-I, and to a lesser extent IGF-II, in intact cells to mediate cellular events. The nature of the signal generated by the IGF-I receptor appears to vary depending on the ligand that occupies it.
Insights
Insulin-like growth factors I and II (IGF-I, IGF-II) activate the IGF-I receptor in canine kidney cells, influencing protooncogene expression differently. IGF-I triggers tyrosine phosphorylation and c-fos induction, while IGF-II has a weaker effect.
Area of Science:
- Cellular signaling
- Molecular biology
- Oncogenesis
Background:
- Tyrosine phosphorylation is crucial for cell signaling pathways.
- Insulin-like growth factors (IGFs) mediate cellular responses through their receptors.
- Protooncogene induction plays a role in cell growth and cancer development.
Purpose of the Study:
- To investigate the role of tyrosine phosphorylation in protooncogene induction by IGF-I and IGF-II.
- To characterize the signaling events mediated by the IGF-I receptor in Madin-Darby canine kidney (MDCK) cells.
- To differentiate the effects of IGF-I and IGF-II on gene expression.
Main Methods:
- Utilized Madin-Darby canine kidney (MDCK) cells lacking significant insulin receptors.
- Assessed tyrosine kinase activity of the IGF-I receptor and its beta-subunit.
- Measured phosphorylation of specific cellular proteins (pp120) and protooncogene mRNA levels (c-fos, c-myc).
Main Results:
- IGF-I specifically stimulated IGF-I receptor tyrosine kinase activity, leading to autophosphorylation and altered pp120 phosphorylation.
- IGF-I induced transient c-fos expression but not c-myc.
- IGF-II showed weaker activation of the IGF-I receptor and did not significantly induce protooncogenes.
Conclusions:
- The IGF-I receptor can be activated by IGF-I and IGF-II to mediate cellular events.
- The signaling outcome differs based on the ligand binding to the IGF-I receptor.
- Tyrosine phosphorylation by IGF-I is a key step in protooncogene induction.